Unichem Laboratories Ltd

506690

Summary

Fair Value Assessment
Overvalued (17% Premium)
Fair ValueQ528.29UncertaintyHigh
Close Price620.65Feb 27, 2025
Market Closed
606.80
Price Down by 13.85 | 2.23 %
Previous Close
620.65
Day Range
600.45 – 652.55
Year Range
433.25 – 949.85
Bid / Ask
Market Cap
42.7 Bil
Volume / Average
5.0 k / 2.6 k
Beta (5-Year)
0.27
Shares Outstanding
70.41 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a global market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
Contact
Off. S. V. Road Unichem Bhavan, Prabhat Estate, Mumbai, MH 400 102
T +91 2266888333
www.unichemlabs.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
2,153

Key Metrics

Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
19.08 16.57 13.02 12.48 11.90 11.56
Revenue Growth %
13.10% 27.26% 4.36% 4.88% 13.37% 3.00%
Gross Profit
11.22 9.73 7.32 8.07 7.89 7.47
Gross Profit Margin %
58.79% 58.68% 56.21% 64.70% 66.27% 64.60%
Operating Income
0.84 -0.13 -1.56 -0.11 0.07 -1.31
Operating Margin %
4.43% -0.78% -11.95% -0.87% 0.61% -11.29%
EBIT
-0.10 -0.40 -1.61 0.21 0.33 -0.80
EBIT Margin %
-0.53% -2.42% -12.33% 1.64% 2.77% -6.90%
EBITDA
1.12 0.73 -0.47 1.12 1.17 0.01
EBITDA Margin %
5.87% 4.41% -3.62% 8.95% 9.86% 0.10%
Net Income
-0.45 -0.70 -2.02 0.33 0.34 -0.60
Net Profit Margin %
-2.35% -4.25% -15.53% 2.65% 2.88% -5.20%
Basic EPS
-6.36 -10.01 -28.72 4.70 4.88 -8.55
Diluted EPS
-6.39 -10.01 -28.72 4.68 4.88 -8.55
Normalized EPS
Total Dividends per Share
4.00 4.00 4.00 4.00
Balance Sheet (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
33.11 31.69 31.93 33.19 31.26 31.45
Total Liabilities
9.10 8.07 7.58 7.00 5.69 6.13
Total Debt
3.00 2.48 3.14 3.49 1.19 2.07
Total Equity
24.01 23.62 24.35 26.18 25.57 25.31
Cash And Cash Equivalents
1.88 1.51 1.84 1.09 0.77 2.26
Working Capital
10.04 9.86 9.49 10.93 8.72 11.20
Shares Outstanding (Bil)
Book Value Per Share
335.11 344.18 370.39 362.06 358.85
Total Debt To Equity
0.13 0.10 0.13 0.13 0.05 0.08
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
1.39 0.17 -0.85 -2.60 0.33 0.20
Cash From Investing Activities
0.13 0.50 2.03 1.00 -0.74 -0.41
Cash From Financing Activities
-0.32 -1.06 -0.81 1.91 -1.21 -0.62
Capital Expenditures
0.23 0.44 1.27 2.88 3.86
Free Cash Flow
0.75 -1.16 -0.37 -1.89 -4.27
Change in Cash
1.20 -0.39 0.36 0.32 -1.62 -0.84

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

Name
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Change Amount
Change %
Date
HDFC Small Cap Gr 7.77 1.24 5,473,134
Jan 31, 2025
DSP Healthcare Fund Reg Gr Not Rated 1.04 1.63 735,591
Jan 31, 2025
Franklin India Opportunities Gr Not Rated 0.74 0.62 518,409
-22,296
4.12%
Jan 31, 2025
ICICI Pru Pharma Healthcare Diag Gr Not Rated 0.38 0.39 270,635
Jan 31, 2025
DFA Emerging Markets Core Equity I 0.28 0.01 194,087
Dec 31, 2024
Total (for Top 5) 10.21 7,191,856
-22,296

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top